{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:20:49Z","timestamp":1791080449545,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,3,27]],"date-time":"2009-03-27T00:00:00Z","timestamp":1238112000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1186\/1471-2369-10-9","type":"journal-article","created":{"date-parts":[[2009,3,30]],"date-time":"2009-03-30T15:08:43Z","timestamp":1238425723000},"source":"Crossref","is-referenced-by-count":29,"title":["Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus"],"prefix":"10.1186","volume":"10","author":[{"given":"Julie","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary C","family":"Curhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,3,27]]},"reference":[{"issue":"12","key":"118_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1056\/NEJMoa011161","volume":"345","author":"BM Brenner","year":"2001","unstructured":"Brenner BM, et al: Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001, 345 (12): 861-9. 10.1056\/NEJMoa011161.","journal-title":"N Engl J Med"},{"key":"118_CR2","doi-asserted-by":"crossref","unstructured":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet. 2000, 355 (9200): 253-9. 10.1016\/S0140-6736(99)12323-7.","DOI":"10.1016\/S0140-6736(99)12323-7"},{"issue":"1","key":"118_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s001250050865","volume":"41","author":"T Fujisawa","year":"1998","unstructured":"Fujisawa T, et al: Meta-analysis of association of insertion\/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 1998, 41 (1): 47-53. 10.1007\/s001250050865.","journal-title":"Diabetologia"},{"issue":"1","key":"118_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1365-2265.2004.02182.x","volume":"62","author":"M Adamczak","year":"2005","unstructured":"Adamczak M, et al: Ageing and plasma adiponectin concentration in apparently healthy males and females. Clin Endocrinol (Oxf). 2005, 62 (1): 114-8. 10.1111\/j.1365-2265.2004.02182.x.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"118_CR5","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1046\/j.1523-1755.2001.00769.x","volume":"60","author":"E Lovati","year":"2001","unstructured":"Lovati E, et al: Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. Kidney International. 2001, 60 (1): 46-54. 10.1046\/j.1523-1755.2001.00769.x.","journal-title":"Kidney International"},{"issue":"2","key":"118_CR6","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1161\/01.HYP.31.2.627","volume":"31","author":"JJ Rogus","year":"1998","unstructured":"Rogus JJ, et al: Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension. 1998, 31 (2): 627-31.","journal-title":"Hypertension"},{"issue":"3","key":"118_CR7","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1046\/j.1365-2141.1996.379915.x","volume":"92","author":"AM Schmidt","year":"1996","unstructured":"Schmidt AM, et al: Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: a marker of vascular dysfunction and progressive vascular disease. Br J Haematol. 1996, 92 (3): 747-50. 10.1046\/j.1365-2141.1996.379915.x.","journal-title":"Br J Haematol"},{"issue":"6","key":"118_CR8","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0272-6386(99)70004-1","volume":"34","author":"A Solini","year":"1999","unstructured":"Solini A, et al: Polymorphisms of angiotensin-converting enzyme and angiotensinogen genes in type 2 diabetic sibships in relation to albumin excretion rate. American Journal of Kidney Diseases. 1999, 34 (6): 1002-9. 10.1016\/S0272-6386(99)70004-1.","journal-title":"American Journal of Kidney Diseases"},{"issue":"6","key":"118_CR9","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1161\/01.HYP.0000072334.34433.17","volume":"41","author":"AA Sethi","year":"2003","unstructured":"Sethi AA, et al: Angiotensinogen single nucleotide polymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension. 2003, 41 (6): 1202-11. 10.1161\/01.HYP.0000072334.34433.17.","journal-title":"Hypertension"},{"issue":"4 Pt 1","key":"118_CR10","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1016\/S0002-8703(99)70226-7","volume":"137","author":"BR Winkelmann","year":"1999","unstructured":"Winkelmann BR, et al: Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J. 1999, 137 (4 Pt 1): 698-705. 10.1016\/S0002-8703(99)70226-7.","journal-title":"Am Heart J"},{"key":"118_CR11","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev.physiol.59.1.395","volume":"59","author":"T Matsusaka","year":"1997","unstructured":"Matsusaka T, Ichikawa I: Biological functions of angiotensin and its receptors. Annual Review of Physiology. 1997, 59: 395-412. 10.1146\/annurev.physiol.59.1.395.","journal-title":"Annual Review of Physiology"},{"issue":"7","key":"118_CR12","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1172\/JCI119343","volume":"99","author":"I Inoue","year":"1997","unstructured":"Inoue I, et al: A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. Journal of Clinical Investigation. 1997, 99 (7): 1786-97. 10.1172\/JCI119343.","journal-title":"Journal of Clinical Investigation"},{"issue":"6","key":"118_CR13","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/S0735-1097(01)01186-X","volume":"37","author":"JC Rodriguez-Perez","year":"2001","unstructured":"Rodriguez-Perez JC, et al: Association of angiotensinogen M235T and A(-6)G gene polymorphisms with coronary heart disease with independence of essential hypertension: the PROCAGENE study. Prospective Cardiac Gene. J Am Coll Cardiol. 2001, 37 (6): 1536-42. 10.1016\/S0735-1097(01)01186-X.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"118_CR14","first-page":"1","volume":"58","author":"M Buraczynska","year":"2003","unstructured":"Buraczynska M, et al: Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol. 2003, 58 (1): 1-9.","journal-title":"Kardiol Pol"},{"issue":"6","key":"118_CR15","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1046\/j.1523-1755.1999.00770.x","volume":"56","author":"JA Miller","year":"1999","unstructured":"Miller JA, Thai K, Scholey JW: Angiotensin II type 1 receptor gene polymorphism predicts response to losartan and angiotensin II[see comment]. Kidney International. 1999, 56 (6): 2173-80. 10.1046\/j.1523-1755.1999.00770.x.","journal-title":"Kidney International"},{"issue":"3","key":"118_CR16","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1001\/jama.293.3.320","volume":"293","author":"JP Forman","year":"2005","unstructured":"Forman JP, et al: Folate intake and the risk of incident hypertension among US women. Jama. 2005, 293 (3): 320-9. 10.1001\/jama.293.3.320.","journal-title":"Jama"},{"issue":"7","key":"118_CR17","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.2337\/diacare.27.7.1680","volume":"27","author":"MB Schulze","year":"2004","unstructured":"Schulze MB, et al: Relationship between adiponectin and glycemic control, blood lipids, and inflammatory markers in men with type 2 diabetes. Diabetes Care. 2004, 27 (7): 1680-7. 10.2337\/diacare.27.7.1680.","journal-title":"Diabetes Care"},{"issue":"2","key":"118_CR18","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1053\/ajkd.2001.21311","volume":"37","author":"KC Abbott","year":"2001","unstructured":"Abbott KC, et al: Graft loss due to recurrent focal segmental glomerulosclerosis in renal transplant recipients in the United States. American Journal of Kidney Diseases. 2001, 37 (2): 366-73. 10.1053\/ajkd.2001.21311.","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"118_CR19","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1093\/ajcn\/82.3.675","volume":"82","author":"MB Schulze","year":"2005","unstructured":"Schulze MB, et al: Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am J Clin Nutr. 2005, 82 (3): 675-84.","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"118_CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/oxfordjournals.aje.a113598","volume":"117","author":"W Willett","year":"1983","unstructured":"Willett W, et al: Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983, 117 (6): 651-8.","journal-title":"Am J Epidemiol"},{"key":"118_CR21","doi-asserted-by":"crossref","unstructured":"Recommendations for healthcare system and self-management education interventions to reduce morbidity and mortality from diabetes. Am J Prev Med. 2002, 22 (4 Suppl): 10-4.","DOI":"10.1016\/S0749-3797(02)00422-1"},{"issue":"1","key":"118_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16 (1): 31-41. 10.1159\/000180580.","journal-title":"Nephron"},{"issue":"19","key":"118_CR23","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/01.CIR.0000066906.11109.1F","volume":"107","author":"M Tanasescu","year":"2003","unstructured":"Tanasescu M, et al: Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation. 2003, 107 (19): 2435-9. 10.1161\/01.CIR.0000066906.11109.1F.","journal-title":"Circulation"},{"issue":"6","key":"118_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1097\/00004872-199816060-00017","volume":"16","author":"AH Danser","year":"1998","unstructured":"Danser AH, et al: Determinants of interindividual variation of renin and prorenin concentrations: evidence for a sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998, 16 (6): 853-62. 10.1097\/00004872-199816060-00017.","journal-title":"J Hypertens"},{"issue":"9","key":"118_CR25","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1681\/ASN.2005101095","volume":"17","author":"JA Miller","year":"2006","unstructured":"Miller JA, et al: Gender differences in the renal response to renin-angiotensin system blockade. J Am Soc Nephrol. 2006, 17 (9): 2554-60. 10.1681\/ASN.2005101095.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"118_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3317\/jraas.2006.015","volume":"7","author":"A Reyes-Engel","year":"2006","unstructured":"Reyes-Engel A, et al: Influence of gender and genetic variability on plasma angiotensin peptides. J Renin Angiotensin Aldosterone Syst. 2006, 7 (2): 92-7. 10.3317\/jraas.2006.015.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"issue":"1","key":"118_CR27","first-page":"27","volume":"28","author":"S Fradin","year":"2002","unstructured":"Fradin S, et al: Relationship between polymorphisms in the renin-angiotensin system and nephropathy in type 2 diabetic patients. Diabetes Metab. 2002, 28 (1): 27-32.","journal-title":"Diabetes Metab"},{"issue":"2","key":"118_CR28","first-page":"725","volume":"108","author":"M Buraczynska","year":"2002","unstructured":"Buraczynska M, et al: [Association of the renin-angiotensin system gene polymorphism with nephropathy in type II diabetes]. Pol Arch Med Wewn. 2002, 108 (2): 725-30.","journal-title":"Pol Arch Med Wewn"},{"issue":"12","key":"118_CR29","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1016\/S0735-1097(03)00487-X","volume":"41","author":"CS Baker","year":"2003","unstructured":"Baker CS, et al: A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study. J Am Coll Cardiol. 2003, 41 (12): 2114-8. 10.1016\/S0735-1097(03)00487-X.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"118_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ki.1996.81","volume":"49","author":"TE Hunley","year":"1996","unstructured":"Hunley TE, et al: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney International. 1996, 49 (2): 571-7. 10.1038\/ki.1996.81.","journal-title":"Kidney International"},{"issue":"8","key":"118_CR31","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/S0026-0495(97)90090-1","volume":"46","author":"C Gutierrez","year":"1997","unstructured":"Gutierrez C, et al: Angiotensin I-converting enzyme and angiotensinogen gene polymorphisms in non-insulin-dependent diabetes mellitus. Lack of relationship with diabetic nephropathy and retinopathy in a Caucasian Mediterranean population. Metabolism. 1997, 46 (8): 976-80. 10.1016\/S0026-0495(97)90090-1.","journal-title":"Metabolism"},{"issue":"2","key":"118_CR32","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0026-0495(96)90057-8","volume":"45","author":"T Ohno","year":"1996","unstructured":"Ohno T, Kawazu S, Tomono S: Association analyses of the polymorphisms of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetics. Metabolism. 1996, 45 (2): 218-22. 10.1016\/S0026-0495(96)90057-8.","journal-title":"Metabolism"},{"issue":"6","key":"118_CR33","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S0272-6386(99)70143-5","volume":"33","author":"TY Wong","year":"1999","unstructured":"Wong TY, et al: Lack of association of angiotensin-converting enzyme (DD\/II) and angiotensinogen M235T gene polymorphism with renal function among Chinese patients with type II diabetes. Am J Kidney Dis. 1999, 33 (6): 1064-70. 10.1016\/S0272-6386(99)70143-5.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"118_CR34","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s001250050662","volume":"40","author":"J Ringel","year":"1997","unstructured":"Ringel J, et al: Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia. 1997, 40 (2): 193-9. 10.1007\/s001250050662.","journal-title":"Diabetologia"},{"issue":"1","key":"118_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00004872-199917010-00003","volume":"17","author":"JA Staessen","year":"1999","unstructured":"Staessen JA, et al: M235T angiotensinogen gene polymorphism and cardiovascular renal risk. J Hypertens. 1999, 17 (1): 9-17. 10.1097\/00004872-199917010-00003.","journal-title":"J Hypertens"},{"key":"118_CR36","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/1471-2350-7-42","volume":"7","author":"P Prasad","year":"2006","unstructured":"Prasad P, et al: Chronic renal insufficiency among Asian Indians with type 2 diabetes: I. Role of RAAS gene polymorphisms. BMC Med Genet. 2006, 7: 42-10.1186\/1471-2350-7-42.","journal-title":"BMC Med Genet"},{"issue":"2","key":"118_CR37","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1681\/ASN.2005050468","volume":"17","author":"CC Hsu","year":"2006","unstructured":"Hsu CC, et al: Genetic variation of the renin-angiotensin system and chronic kidney disease progression in black individuals in the atherosclerosis risk in communities study. J Am Soc Nephrol. 2006, 17 (2): 504-12. 10.1681\/ASN.2005050468.","journal-title":"J Am Soc Nephrol"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-10-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-10-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:10:47Z","timestamp":1548213047000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-10-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3,27]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["118"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-10-9","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,3,27]]},"article-number":"9"}}